Loading...

TruBridge, Inc.

TBRGNASDAQ
Healthcare
Medical - Healthcare Information Services
$19.87
$-0.61(-2.98%)

TruBridge, Inc. (TBRG) Financial Performance & Income Statement Overview

Access detailed quarterly and annual financial reports for TruBridge, Inc. (TBRG), covering cash flow, earnings, and balance sheets.

Revenue Growth
0.95%
0.95%
Operating Income Growth
115.57%
115.57%
Net Income Growth
55.36%
55.36%
Operating Cash Flow Growth
2934.47%
2934.47%
Operating Margin
6.59%
6.59%
Gross Margin
57.30%
57.30%
Net Profit Margin
-3.55%
3.55%
ROE
-7.23%
7.23%
ROIC
6.74%
6.74%

TruBridge, Inc. (TBRG) Income Statement & Financial Overview

Explore comprehensive income reports for TruBridge, Inc. TBRG, broken down by year and quarter.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$87.21M$90.84M$83.83M$84.73M
Cost of Revenue$39.51M$47.80M$42.37M$52.85M
Gross Profit$47.70M$49.78M$41.46M$31.88M
Gross Profit Ratio$0.55$0.55$0.49$0.38
R&D Expenses$8.25M$7.83M$7.74M$8.21M
SG&A Expenses$24.87M$26.05M$25.32M$22.11M
Operating Expenses$33.12M$40.61M$39.52M$30.31M
Total Costs & Expenses$72.63M$67.59M$81.89M$83.16M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense-$3.38M$3.82M$4.03M$4.24M
Depreciation & Amortization$0.00$6.74M$6.46M$9.51M
EBITDA$8.16M$10.62M$8.03M$6.58M
EBITDA Ratio$0.09$0.12$0.10$0.08
Operating Income$8.16M$9.17M$1.94M$1.57M
Operating Income Ratio$0.09$0.10$0.02$0.02
Other Income/Expenses (Net)-$3.24M-$5.63M-$4.41M-$4.15M
Income Before Tax$4.92M$3.54M-$2.46M-$7.17M
Income Before Tax Ratio$0.06$0.04-$0.03-$0.08
Income Tax Expense$4.46M$6.60M$7.34M-$2.12M
Net Income$459000.00-$3.06M-$9.81M-$4.83M
Net Income Ratio$0.005-$0.03-$0.12-$0.06
EPS$0.03-$0.00$0.45-$0.34
Diluted EPS$0.03-$0.00$0.45-$0.34
Weighted Avg Shares Outstanding$14.37M$14.30M$14.32M$14.31M
Weighted Avg Shares Outstanding (Diluted)$14.37M$14.30M$14.32M$14.31M

Over the past four quarters, TruBridge, Inc. demonstrated steady revenue growth, increasing from $84.73M in Q2 2024 to $87.21M in Q1 2025. Operating income reached $8.16M in Q1 2025, maintaining a consistent 9% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $8.16M, reflecting operational efficiency. Net income rose to $459000.00, with EPS at $0.03. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;